GHRP-6 prices

FROM PEPTIDES CALCULATOR

About GHRP-6

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

GHRP-6 is the first of Cyril Bowers' synthetic growth hormone-releasing hexapeptides, a six-amino-acid ghrelin-receptor agonist whose discovery in the early 1980s led to the identification of ghrelin itself. Human pharmacology studies from 1990 onward showed that 1 mcg/kg intravenously, 15-30 mcg/kg intranasally or about 300 mcg/kg orally releases GH, that a 24-hour infusion raises pulsatile GH and IGF-I, and that it also stimulates appetite, prolactin and cortisol. Cuban researchers later developed it as a cytoprotective drug (CIGB-500), publishing a pig infarct study and a single-dose phase 1 safety and pharmacokinetic program in healthy men. It has no approved therapeutic use anywhere, is prohibited in sport as a GH secretagogue according to the sources below, and the 100-300 mcg subcutaneous schedules in circulation are community conventions rather than trial regimens.

Formula

C46 H56 N12 O6

Molar mass

873 g/mol

CAS number

87616-84-0

Amino acids

6

Research evidence described in the source

Limitations noted in the source

• Individual claims and source links have not yet completed editorial verification.
• Evidence level, applicable study model, formulation, route and population remain unassigned.

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.